Cargando…
Pharmacophore-based discovery of FXR-agonists. Part II: Identification of bioactive triterpenes from Ganoderma lucidum
The farnesoid X receptor (FXR) belonging to the metabolic subfamily of nuclear receptors is a ligand-induced transcriptional activator. Its central function is the physiological maintenance of bile acid homeostasis including the regulation of glucose and lipid metabolism. Accessible structural infor...
Autores principales: | Grienke, Ulrike, Mihály-Bison, Judit, Schuster, Daniela, Afonyushkin, Taras, Binder, Markus, Guan, Shu-hong, Cheng, Chun-ru, Wolber, Gerhard, Stuppner, Hermann, Guo, De-an, Bochkov, Valery N., Rollinger, Judith M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3254236/ https://www.ncbi.nlm.nih.gov/pubmed/22014750 http://dx.doi.org/10.1016/j.bmc.2011.09.039 |
Ejemplares similares
-
Pharmacophore-based discovery of FXR agonists. Part I: Model development and experimental validation
por: Schuster, Daniela, et al.
Publicado: (2011) -
Anticancer effect of triterpenes from Ganoderma lucidum in human prostate cancer cells
por: Qu, Lijun, et al.
Publicado: (2017) -
Structure Identification and Anti-Cancer Pharmacological Prediction of Triterpenes from Ganoderma lucidum
por: Shao, Yanyan, et al.
Publicado: (2016) -
Triterpenes and Aromatic Meroterpenoids with Antioxidant Activity and Neuroprotective Effects from Ganoderma lucidum
por: Wang, Cuifang, et al.
Publicado: (2019) -
Identification of Novel
Liver X Receptor Activators
by Structure-Based Modeling
por: von Grafenstein, Susanne, et al.
Publicado: (2012)